Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
16.9M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1.91M
-
Shares change
-
+34.1K
-
Total reported value, excl. options
-
$10.5M
-
Value change
-
+$188K
-
Number of buys
-
5
-
Number of sells
-
-7
-
Price
-
$5.50
Significant Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q4 2023
26 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.91M shares
of 16.9M outstanding shares and own 11.3% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1.07M shares), Aisling Capital Management LP (314K shares), VANGUARD GROUP INC (225K shares), WEDBUSH SECURITIES INC (69.5K shares), GEODE CAPITAL MANAGEMENT, LLC (60K shares), NORTHERN TRUST CORP (38.7K shares), RENAISSANCE TECHNOLOGIES LLC (37.6K shares), DIMENSIONAL FUND ADVISORS LP (20.3K shares), STATE STREET CORP (19.7K shares), and Creative Planning (17.3K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.